American Journal of Epidemiology Vol. 148, No. 9: 859-868
Copyright © 1998 by The Johns Hopkins University School of Hygiene and Public Health
other |
Association of Apolipoprotein E Phenotype with Plasma Lipoproteins in African-American and White Young Adults
The CARDIA Study
1Medlantic Research Institute Washington, DC
2Department of Pediatrics, Northwestern University Medical School Chicago, IL
3Department of Preventive Medicine, Northwestern University Medical School Chicago, IL
Reprint requests to Dr. Barbara V. Howard, Medlantic Research Institute, 108 Irving Street, N.W., Washington, DC 20010-2933.
Apolipoprotein E phenotype (APOE phenotype) has been demonstrated to be a genetic determinant of cardiovascular disease. This atherogenicity may be a reflection of the association of APOE phenotype and plasma lipoprotein concentrations. The Coronary Artery Risk Development in Young Adults (CARDIA) Study affords the opportunity to assess the frequency of apolipoprotein E alleles in population-based samples of African Americans and whites in the United States and to compare the associations of APOE phenotype with lipoprotein and apoprotein concentrations. Data from 3, 485 African-American and white men and women between the ages of 25 and 37 years who attended the fourth CARDIA Study examination in 19921993 were used in this analysis. African-American men and women had significantly higher frequencies of E2 and E4 phenotype and thus higher frequencies of *e2 and *e4 alleles (p > 0.005). Men and women of both races with APOE4 phenotype generally had higher low density lipoprotein cholesterol, apolipoprotein B, and lipopro-tein(a) concentrations and lower high density lipoprotein cholesterol concentration, and individuals with APOE3 phenotype had the lowest triglyceride concentration. Major differences between African Americans and whites were observed in the distribution of APOE phenotypes and *e alleles, but APOE phenotype was associated with similar differences in lipoprotein and apoprotein concentrations in both races. The data suggest that APOE phenotype may be a risk factor for cardiovascular disease in both African Americans and whites because it is associated similarly with an adverse lipoprotein profile. Am J Epidemiol 1998; 148: 85968.
apolipoproteins E; blacks; cardiovascular desease; lipoproteins(a); men; whites; women
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Liew, A. Shankar, J. J. Wang, R. Klein, M. S. Bray, D. J. Couper, A. R. Sharrett, and T. Y. Wong Apolipoprotein E Gene Polymorphisms and Retinal Vascular Signs: The Atherosclerosis Risk in Communities (ARIC) Study Arch Ophthalmol, June 1, 2007; 125(6): 813 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Anuurad, J. Rubin, G. Lu, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol J. Lipid Res., November 1, 2006; 47(11): 2475 - 2481. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Bond, R. Burr, S. M. Mccurry, M. M. Rice, A. R. Borenstein, W. A. Kukull, L. Teri, J. D. Bowen, W. C. Mccormick, and E. B. Larson Alcohol, Gender, and Cognitive Performance: A Longitudinal Study Comparing Older Japanese and Non-Hispanic White Americans J Aging Health, November 1, 2004; 16(5): 615 - 640. [Abstract] [PDF] |
||||
![]() |
K. G Manton, X. Gu, H. Huang, and M. Kovtun Fuzzy set analyses of genetic determinants of health and disability status Statistical Methods in Medical Research, October 1, 2004; 13(5): 395 - 408. [Abstract] [PDF] |
||||
![]() |
J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Isasi, S. Shea, R. J. Deckelbaum, S. C. Couch, T. J. Starc, J. D. Otvos, and L. Berglund Apolipoprotein epsilon 2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study Pediatrics, September 1, 2000; 106(3): 568 - 575. [Abstract] [Full Text] |
||||





